- Home
- IINN vs DARE Comparison
IINN vs DARE Comparison
Compare IINN & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- DARE
- Stock Information
- Founded
- IINN 2018
- DARE 2015
- Country
- IINN Israel
- DARE United States
- Employees
- IINN N/A
- DARE N/A
- Industry
- IINN Medical/Dental Instruments
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- IINN Health Care
- DARE Health Care
- Exchange
- IINN Nasdaq
- DARE Nasdaq
- Market Cap
- IINN 34.1M
- DARE 28.0M
- IPO Year
- IINN 2021
- DARE N/A
- Fundamental
- Price
- IINN $1.17
- DARE $2.03
- Analyst Decision
- IINN Strong Buy
- DARE Strong Buy
- Analyst Count
- IINN 1
- DARE 2
- Target Price
- IINN $2.00
- DARE $10.00
- AVG Volume (30 Days)
- IINN 1.6M
- DARE 123.1K
- Earning Date
- IINN 11-14-2025
- DARE 11-13-2025
- Dividend Yield
- IINN N/A
- DARE N/A
- EPS Growth
- IINN N/A
- DARE N/A
- EPS
- IINN N/A
- DARE N/A
- Revenue
- IINN N/A
- DARE N/A
- Revenue This Year
- IINN N/A
- DARE $6,864.02
- Revenue Next Year
- IINN $2,050.00
- DARE $4,922.46
- P/E Ratio
- IINN N/A
- DARE N/A
- Revenue Growth
- IINN N/A
- DARE N/A
- 52 Week Low
- IINN $0.40
- DARE $1.83
- 52 Week High
- IINN $1.65
- DARE $9.19
- Technical
- Relative Strength Index (RSI)
- IINN 47.17
- DARE 39.93
- Support Level
- IINN $1.13
- DARE $2.05
- Resistance Level
- IINN $1.31
- DARE $2.15
- Average True Range (ATR)
- IINN 0.08
- DARE 0.07
- MACD
- IINN 0.00
- DARE 0.02
- Stochastic Oscillator
- IINN 30.00
- DARE 15.54
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.